|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 19 March 2009
doi: 10.1242/jcs.038323
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
1 MRC Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, UK
2 Molecular Medicine Unit, UCL Institute of Child Health, University College London, London WC1E 6BT, UK
3 Department of Genetics, Evolution and Environment, University College London, London WC1E 6BT, UK
* Author for correspondence (e-mail: s.mole{at}ucl.ac.uk)
Accepted 16 December 2008
| Summary |
|---|
|
|
|---|
cells. Our data also implicate btn1 in other Vps10-independent Cpy1-sorting pathways. Furthermore, btn1 affects the number, intracellular location and structure of Golgi compartments. We show that the prevacuole location of Btn1p is at the Golgi, because Btn1p colocalises predominantly with the Golgi marker Gms1p in compartments that are sensitive to Brefeldin A. Btn1p function might be linked to that of Vps34p, a phosphatidylinositol 3-kinase, because Btn1p acts as a multicopy suppressor of the severe Cpy1p vacuole protein-sorting defect of vps34
cells. Together, these results indicate an important role for Btn1p in the Golgi complex, which affects Golgi homeostasis and vacuole protein sorting. We propose a similar role for CLN3 in mammalian cells.
Key words: CLN3, btn1, Batten, Neuronal ceroid lipofuscinosis, vps10, Carboxypeptidase Y, Vacuole, Golgi, Neurodegeneration, S. pombe
| Introduction |
|---|
|
|
|---|
The conservation of CLN3 in single-celled eukaryotes suggests that it has a fundamental role in eukaryotic cells. To help understand its function, we used a simple model system, the fission yeast Schizosaccharomyces pombe. We previously showed that deletion of btn1, the fission yeast orthologue of CLN3, affects vacuole homeostasis, causing an increase in the size of the vacuoles, which are equivalent to lysosomes (Kitzmüller et al., 2008
), and a decrease in vacuole pH (Gachet et al., 2005
), as occurs in cells from a JNCL patient (Holopainen et al., 2001
). Importantly, and validating our approach, Btn1p and CLN3 have been shown to be functional orthologues, because expression of CLN3 is able to rescue multiple defects of btn1
cells (Codlin et al., 2008b
; Gachet et al., 2005
). Similarly, BTN1, the orthologous gene from Saccharomyces cerevisiae, has also been implicated in vacuole homeostasis (Chattopadhyay et al., 2000
; Kim et al., 2003
; Padilla-Lopez and Pearce, 2006
; Pearce et al., 1999
; Pearce and Sherman, 1998
), as well as in the response to oxidative stress (Osorio et al., 2007
).
In S. pombe, GFP-Btn1p traffics unusually slowly to the vacuole (Gachet et al., 2005
), compared with other vacuole membrane proteins (Bellemare et al., 2002
; Gaits and Russell, 1999
; Iwaki et al., 2003
). At steady state, Btn1p is not predominantly localised to the vacuole, but is mainly located in unidentified prevacuole compartments (Gachet et al., 2005
). Trafficking studies in a ypt7-null strain, defective for fusion with the vacuole, showed that Btn1p has a functional role in these prevacuole compartments that affects vacuole homeostasis (Gachet et al., 2005
). This was the first clear indication that Btn1p (and, therefore, possibly CLN3) has a function that is not at the vacuole or lysosome. This might underlie the pleiotropic phenotypes previously recognised in cells deleted for btn1 (Codlin et al., 2008a
; Codlin et al., 2008b
; Gachet et al., 2005
).
Since Btn1p is involved in vacuole homeostasis in both S. pombe (Gachet et al., 2005
) and S. cerevisiae (Kim et al., 2003
; Pearce et al., 1999
; Pearce and Sherman, 1998
), and all NCL genes affect lysosomal function, with some encoding lysosomal hydrolases, we wondered whether Btn1p has a role in the trafficking of vacuole-bound hydrolases. The best-studied vacuole protein-sorting (vps) pathway in yeasts is that of the hydrolase carboxypeptidase Y (Cpy1). The major sorting receptor for this hydrolase is the type 1 receptor Vps10p (official symbol Pep1p) (Iwaki et al., 2006
), which binds Cpy1p in the trans-Golgi network (TGN) and releases it in late endosomes for onward trafficking to the vacuole. Recycling of Vps10p back to the TGN for further rounds of Cpy1p sorting is dependent on the retromer complex (Iwaki et al., 2006
), and expression of Vps10p in retromer deletion strains, e.g. vps26
, causes it to be mistargeted to the vacuole membrane, because it can no longer be recycled back to the TGN. Cpy1p trafficking is used as a marker phenotype of vacuole protein-sorting defects, and mis-sorting of Cpy1p at any stage of this pathway, for example by deletion of vps10 or retromer components, leads to its secretion from the cell (Iwaki et al., 2006
; Robinson et al., 1988
; Rothman and Stevens, 1986
).
In this study, we found that Btn1p in S. pombe is required for vacuole protein sorting of Cpy1p and for post-Golgi trafficking of its receptor, Vps10p. It is also implicated in other Cpy1p vacuole protein-sorting pathways. Furthermore, we show that this might occur through a direct effect on the Golgi compartment, because Btn1p is predominantly located in the Golgi complex at steady state, and changes in the level of expression of btn1 affect the number, location and morphology of these compartments.
| Results |
|---|
|
|
|---|
cells are defective in vacuole protein-sorting of Cpy1p
strain was included as a negative control for the antibody, and the vps26
or vps10
strains as positive controls, because both secrete easily detectable levels of Cpy1p (Iwaki et al., 2006
strain secreted Cpy1p protein, whereas wild-type cells secrete only a minimal amount of Cpy1p (Fig. 1A). The amount of Cpy1p secreted by btn1
cells was consistent over several experiments and, as determined by densitometry (Fig. 1B), was similar to the moderate amount secreted by the retromer mutant strain vps26
, in which Vps10p cannot be recycled back to the TGN, and was slightly less than that of vps10
cells, which lack its major sorting receptor. Thus, btn1
cells exhibit a moderate Cpy1p sorting defect.
|
strain. In wild-type cells, Vps10p predominantly localises to multiple cytoplasmic punctae (Fig. 2A), typical of the Golgi or TGN (Iwaki et al., 2006
cells, we observed a reduced number of punctae and the appearance of structures that were perinuclear and cortical, with ribbon-like connective tubules (Fig. 2B), typical of the S. pombe endoplasmic reticulum (ER) (Gachet et al., 2005
|
We explored this location defect further. We compared the trafficking and final location of Vps10p after its expression was repressed by the incorporation of thiamine into the medium (which inhibits the nmt promoter system of the pREP expression plasmids). In wild-type cells, most ectopically expressed Vps10p was re-routed to the vacuole within 3 hours of promoter repression (Fig. 2C), although some punctate stained compartments remained. This is probably due to protein turnover or saturation of the retromer system, such that excess Vps10p is degraded at the vacuole, as previously demonstrated (Cereghino et al., 1995
; Iwaki et al., 2006
). By contrast, gene repression studies in btn1
cells did not have the same effect. In these cells, Vps10p was not evident at the vacuole after 3 hours (Fig. 2D), nor was it retained in the ER. Instead, Vps10p was held within a few distinct cytoplasmic compartments. These compartments did not resemble endocytic compartments, because of their low number and dispersed location, but did resemble those of the S. pombe Golgi complex (Vjestica et al., 2008
). To confirm the identity of these compartments, we treated these btn1
cells with brefeldin A (BFA). BFA causes the Golgi complex (cis-, medial- and trans-Golgi), but not the trans-Golgi network (TGN) or later compartments, to be redistributed back to the ER (Brazer et al., 2000
), as in mammalian cells (Lippincott-Schwartz et al., 1989
). This effect is due to inhibition of Arf1p-dependent vesicle formation. The TGN remains unaffected. We found that, upon BFA treatment, the bright Vps10p-containing punctae of btn1
cells (Fig. 2E) were replaced by the classic perinuclear and cortical ER pattern (Fig. 2F), as observed with BFA treatment of Golgi markers Gms1p and Anp1p (supplementary material Fig. S2A; Fig. 2B). This indicates that the observed punctae, before BFA treatment, are Golgi compartments. The same treatment in wild-type cells, in which Vps10p had trafficked for 3 hours following gene repression, had no effect on the location of Vps10p (Fig. 2G), which by this time had exited the Golgi and TGN and was predominantly at the vacuole (Fig. 2C). Together, these data show that, in the absence of btn1, Vps10p is delayed in its trafficking through the ER and Golgi, and that its exit from the Golgi, and progression to the TGN and into the vps pathway, is severely impeded.
Btn1p localises to the Golgi complex
Btn1p has a functional role in previously unidentified prevacuole compartments that affects vacuole function (Gachet et al., 2005
), and here we have shown that Btn1p is required for Cpy1 sorting and exit of Vps10p from the Golgi. We therefore explored whether the prevacuole location of Btn1p was at the Golgi complex. We found extensive colocalisation of GFP-Btn1p with the Golgi marker Gms1p-CFP at steady state in wild-type cells (Fig. 3A), with few compartments exclusive for Gms1p or Btn1p (Fig. 3B). This colocalisation was observed at low levels of expression of GFP-Btn1p (Fig. 3A, asterisk) as well as at higher levels (remaining cells), making it unlikely to be due to protein overexpression. This Golgi localisation was found to be specific to the native protein, because Btn1p containing the equivalent of a JNCL disease mis-sense mutation, Gly187Ala (Btn1pG136A) (www.ucl.ac.uk/ncl/cln3.shtml), which affects trafficking (Gachet et al., 2005
), did not colocalise with Gms1p (Fig. 3C). Rather, this mutant protein was retained within structures typical of the S. pombe ER. Hence, ectopically expressed GFP-Btn1p resides predominantly at the Golgi compartment.
|
Btn1p is located in an earlier Golgi compartment than Vps10p
To confirm that the compartments in which Btn1p colocalised with Gms1p were indeed the Golgi, we treated these cells with BFA. Exposure to BFA caused GFP-Btn1p (Fig. 4A) to redistribute back to the ER within 1 hour, as previously shown for the Golgi markers Gms1p (supplementary material Fig. S2A) or Anp1p (supplementary material Fig. S2B). By contrast, Vps10p-YFP remained in punctate cytoplasmic compartments, with minimal ER localisation (Fig. 4B), even after 2 hours of BFA treatment (data not shown). Btn1p, therefore, is predominantly located within the Golgi complex, whereas Vps10p is predominantly located in later compartments, probably TGN, but possibly endosomal compartments, between which it cycles. These data are consistent with the Gms1p colocalisation (Fig. 3A; Fig. 4C,D), since Vps10p was more often found in punctate structures adjacent to Gms1p-positive Golgi compartments, rather than in these compartments. In addition, unlike Vps10p (supplementary material Fig. S3A; Fig. 4F), Btn1p was not misrouted to the vacuole in the absence of functional retromer: as in vps26
cells, it remained in pre-vacuolar Golgi compartments (supplementary material Fig. S3B) that were sensitive to BFA treatment (Fig. 4E).
|
Golgi number and positioning defects in btn1
cells
Given the predominant location of expressed Btn1p in the Golgi compartment, and since Golgi exit of Vps10p appears to be the most upstream defect so far described in btn1
cells, we tested whether absence or overexpression of Btn1p affected the Golgi compartments in any way. For this, we monitored the location and number of Gms1p-positive Golgi structures by fluorescence microscopy. Since these compartments can vary in size, location and number according to the stage of the cell cycle (Ayscough et al., 1993
; Vjestica et al., 2008
), we monitored those compartments only in similarly sized interphase cells, in one focal plane that bisected the nucleus. Despite the slightly diffuse background associated with this CFP marker, we observed highly significant differences in the number and positioning of the visible punctate Gms1p-positive Golgi compartments between wild-type and btn1
cells. First, there were fewer Gms1p-punctae in btn1
cells, with an average of four per field of view, compared with seven in wild-type cells (Fig. 5A,B). We also noted that one or two of these punctae were particularly prominent in btn1
cells. Maximum projection images of 0.3 µm z-sections through btn1
and wild-type cells expressing Gms1p-CFP were used to display all Golgi compartments (supplementary material Fig. S4), and these and the corresponding movies (supplementary material Movies 1 and 2) confirmed a reduction in the total number of Golgi compartments in btn1
cells compared with wild-type cells (Vjestica et al., 2008
). Thus, loss of btn1 had an impact on the number of Golgi compartments.
|
cells displayed more Golgi at the cell tip region (region a) (33% compared with 10% in wild-type cells), and less in a perinuclear location (region e) (4% compared with 10% in wild-type cells) (Fig. 5C). This was also confirmed by maximal projection images (supplementary material Fig. S4). Thus, loss of btn1 has an impact on Golgi positioning within the cell.
Interestingly, cells overexpressing Btn1p also exhibited some defects in Golgi compartment distribution (Fig. 3A; Fig. 5C), similarly to that of the btn1
strain (Fig. 5C), with more Gms1p-positive Golgi compartments at the cell tip region and less at the perinuclear region, when compared with wild-type cells. Also, although the number of Golgi compartments was not significantly different from that of wild-type cells, we again noted that one or two compartments per cell were visibly brighter and possibly larger (Fig. 3A). This could be due to a change in size or morphology of these compartments. Overall, therefore, our data suggest that the level of expression of Btn1 protein affects Golgi homeostasis.
btn1 affects Golgi morphology
To define the effects of btn1, we used electron microscopy to compare the morphology of the Golgi complex between wild-type and btn1
cells. The morphology of S. pombe Golgi resemble those of mammalian cells (Chappell and Warren, 1989
). In wild-type cells, the multiple Golgi were easily recognisable as electron-dense ribbons or flattened cisternae of length
0.5-0.8 µm, often with a globular (or beaded) appearance (Fig. 6A,B). Most had one, two or three adjacent ribbons, and occasionally more (Fig. 6E), and were distributed throughout the cytoplasm, often near the nucleus (Fig. 6A,B). There were few Golgi that did not have this typical ultrastructure. By contrast, in btn1
cells, there were less recognisable Golgi per cell, the ribbons of these were slightly longer (>1 µm) (Fig. 6C,D), and there were fewer with three or more adjacent cisternae (Fig. 6E). There was, however, an increase in the number of structures that appeared to be misshapen Golgi (34% compared with 5% in wild-type cells), some with extremely contorted and swollen compartments, often more than 1.3 µm in diameter across the whole structure. These Golgi were usually not located near the nucleus (Fig. 6C,D). Thus, deletion of btn1 has a striking effect on Golgi morphology.
|
Btn1p may be required for more than one Cpy1 vacuole protein sorting pathway
To provide insight into the role and possible mechanism of action of btn1, we explored whether loss or increased expression of Btn1p affected the Cpy1p vacuole protein-sorting defect of vps strains deleted for vps10, vps26 and vps34. First, we investigated the effect of loss of btn1 on Cpy1p sorting in vps strains. We derived the double mutant strain, vps10
btn1
, and assayed for altered Cpy1p secretion compared with that in parental strains. Interestingly, significantly more Cpy1p was secreted when both vps10 and btn1 genes were deleted, in comparison to the parental strains (Fig. 7A,D). This suggests that Btn1p might act in more than one Cpy1p vps pathway. The amount of Cpy1p secreted was similar to that of the vps34
strain (Fig. 7B,D), which has the most severe Cpy1p sorting defect associated with deletion of a single gene (Iwaki et al., 2004
; Tabuchi et al., 1997
; Takegawa et al., 1995
), presumably because, in addition to a direct effect on the vps pathway, Vps34p also acts at several other steps in the cell (Burda et al., 2002
; Futter et al., 2001
; Lawe et al., 2000
; Wurmser and Emr, 2002
; Yan and Backer, 2007
; Zeng et al., 2006
), including the Golgi (Deloche et al., 2001
; Hall et al., 2006
). These high levels of Cpy1p secretion from vps10
btn1
cells (Fig. 7D) suggest that loss of both vps10 and btn1 severely impacts the correct trafficking Cpy1p. We then derived the double deletion strain vps34
btn1
and, surprisingly, found that even more Cpy1p was secreted by cells deleted for both vps34 and btn1 than the parental strains (Fig. 7B and shorter exposure Fig. 7C,D). This supports the importance of btn1 in more than one Cpy1p vacuole protein-sorting pathway. We also derived the double mutant strain vps26
btn1
, and found that the level of Cpy1p secreted from this strain was similar to that of both parental strains (Fig. 7B, Fig. 1C). This suggests that the Cpy1 secretion defect associated with loss of btn1 affects the same pathway as the defect arising from that of a loss of retromer function. Considering the respective locations of Btn1p and retromer, Btn1p probably acts upstream of retromer.
|
Btn1p suppresses the Cpy1p secretion defect of vps34
cells
To investigate the effect of increased expression of Btn1p on Cpy1p sorting in vps strains, we first confirmed that the secretion defect of btn1
cells was rescued by ectopic expression of GFP-Btn1p (supplementary material Fig. S5Ai), which was predominantly localised to BFA-sensitive Golgi compartments in these cells, as in wild-type cells (supplementary material Fig. S5B), and which rescued other previously described pleiotropic phenotypes of btn1
cells (Codlin et al., 2008a
; Codlin et al., 2008b
; Gachet et al., 2005
). This rescue was specific to native protein because there was no rescue by expression of GFP alone (empty vector), or GFP-Btn1pG136A mutant protein, which was predominantly localised to the ER (Gachet et al., 2005
). Importantly, the Cpy1p secretion defect of btn1
cells was also effectively rescued by expression of GFP-CLN3 (supplementary material Fig. S5Aii), further supporting the use of S. pombe as a model organism to understand CLN3 function.
The Cpy1 secretion defects of the vps10
cells and vps26
cells were not significantly altered by expression of Btn1p (Fig. 8A,B; supplementary material Fig. S6A), but did show a small increase in Cpy1p secretion. Interestingly, the Cpy1 secretion defect of the vps34
strain was significantly decreased by expression of Btn1p (Fig. 8A-C; supplementary material Fig. S6A,B), which was localised to BFA-sensitive Golgi complex in these cells, as in wild-type cells (supplementary material Fig. S5C). To confirm that this decrease in Cpy1p secretion by vps34
cells was a result of Btn1p activity, we expressed the mutant GFP-Btn1pG136A protein in this strain. Expression of this mutant Btn1p protein in vps34
cells did not rescue the Cpy1p secretion defect of vps34
cells; rather, the level of Cpy1p secretion was significantly increased (Fig. 8C,D; supplementary material Fig. S6B), perhaps because of its location in the ER (supplementary material Fig. S5D). This suggests that excess mutant Btn1p protein further exacerbated the secretion defect of vps34
cells, consistent with the Cpy1 secretion data observed for the vps34
btn1
double mutant strain (Fig. 8C,D and Fig. 7D). To confirm that these effects were due to expression of these proteins, we inhibited their expression in vps34
cells using thiamine and performed colony blots of those cells, and found that there was now no difference in Cpy1p secretion (Fig. 8E,F; supplementary material Fig. S6B). Overall, these data suggest that the action of Btn1p can compensate for, or bypass, a lack of phosphatidylinositol 3-kinase activity in Cpy1p sorting.
|
| Discussion |
|---|
|
|
|---|
|
We previously showed that Btn1p affects vacuole size and pH from prevacuole compartments (Gachet et al., 2005
). We have now identified these as the Golgi complex, because they are sensitive to BFA, and because Btn1p extensively colocalises with the Golgi membrane-resident protein UDP-galactose transporter (Gms1p), part of the SLC35A family, which transport nucleotide sugars from the cytosol into the Golgi (Tanaka and Takegawa, 2001
). We propose that Btn1p acts primarily at the Golgi compartment, where it is important for downstream vps pathways that consequently impact vacuole function. Data from the study supporting include: (1) the retardation of Vps10p in the Golgi when btn1 is deleted; (2) the rescue of the Cpy1p sorting defect and vacuole defects by Btn1p located predominantly in a BFA-sensitive compartment; (3) the lack of rescue of these phenotypes upon expression of the Btn1pG136A mutant protein; (4) the effect on the number and location of Golgi compartments when btn1 is deleted; and (5) the aberrant Golgi structures visualised by EM in btn1
cells. We can also infer that the level of expression of Btn1p matters and is likely to be tightly regulated, because both its absence and overexpression affect the Golgi and vacuole compartments, and TGN-to-vacuole trafficking. Exactly how Btn1p affects Golgi size, positioning and structure remains to be determined. Btn1p may be more important for older or more active Golgi, because the number of stacks, as well as the total number of Golgi, is thought to increase during the cell cycle (Ayscough et al., 1993
; Vjestica et al., 2008
), and it is these structures that appear to be most affected in btn1
cells.
Some clues to Btn1p action might be provided by the discovery that it acts as a multicopy suppressor of vps34, because overexpression of Btn1p in vps34
cells specifically overcomes the severe mis-sorting of Cpy1p (Tabuchi et al., 1997
). Vps34p, a phosphatidylinositol 3-kinase that makes phosphatidylinositol 3-phosphate, or some of its recruited downstream effectors, are known to affect many cellular processes, including events at the Golgi (Deloche et al., 2001
; Hall et al., 2006
; Ridley et al., 2001
) and trafficking to the vacuole (Kihara et al., 2001
; Stack et al., 1995
; Takegawa et al., 1995
). Expression of Btn1p might facilitate the action of one or more of these effectors, permit bypass of a particular vps34-dependent pathway, or relieve a Golgi defect.
Interestingly, because vacuole defects associated with loss of btn1 can be rescued by growth in acidic media (pH 4) (Gachet et al., 2005
), as can the Cpy1p mis-sorting defect (our unpublished data), we cannot rule out a role for Btn1p in pH homeostasis, with alteration of Btn1p levels perhaps affecting the ionic environment within the lumen of the Golgi complex. This might, in turn, affect protein and lipid modification of receptors or cargo, or membrane remodelling and budding, causing the observed defect in Golgi structure, and leading to the retention of proteins such as Vps10p within the Golgi, and downstream sorting defects. This could be via a direct affect, because Btn1p shares distant sequence homology with transporters (Baldwin et al., 2004
; Finn et al., 2006
; Lobley et al., 2007
), or, more likely, by affecting the activity or trafficking of transporters or channels, including those known to cause NCL (Cooper et al., 2006
; Siintola et al., 2006
; Siintola et al., 2007
). Consistent with this, Btn1p is a multicopy suppressor of the vacuole defects of V-type H+ ATPase (v-ATPase)-null cells (Codlin et al., 2008a
), as well as their Cpy1p missorting defect (our unpublished data). We recently reported that Btn1p is essential for growth of S. pombe at high temperatures, with failure to correctly polarise sterol-rich domains at the plasma membrane, because of defective formation and polarisation of F-actin patches, disruption of endocytosis, and loss of Myo1p localisation (Codlin et al., 2008b
). It is plausible that, in addition to vps pathways, Btn1p is required for other post-Golgi trafficking pathways that are required to deliver key proteins, particularly at high temperatures. This remains to be investigated.
It also remains to be determined whether the effect of loss of btn1 on Vps10p and Vps10p-independent trafficking affects the targeting and activity of other vacuole hydrolases, in addition to Cpy1p. This is likely, because Vps10p, a type 1 sorting receptor, is known to facilitate the trafficking of several vacuole hydrolases in yeasts (Cooper and Stevens, 1996
). Vps10p has long been considered the functional equivalent of the mammalian mannose-6-phosphate receptor (M6PR), despite fundamental differences in cargo recognition (Dahms et al., 1989
; Valls et al., 1990
). However, the M6PR yeast homologue is more likely to be the product of the less-studied mrl1 gene (Whyte and Munro, 2001
). Our data suggests that loss of btn1 will also affect the trafficking of Mrl1p, and the localisation of other vacuole hydrolases such as Isp6p and Psp3p (Iwaki et al., 2006
), that might use this pathway.
Vps10p is now recognised as structurally and functionally similar to mammalian sortilins, a family of type 1 sorting receptors that act in transport pathways from the TGN, some of which have specialised functions in neurons. Since the TGN is the major protein-sorting compartment of the cell, the determination of the effect of mutations in CLN3 on the localisation and trafficking of the sortilins and M6PRs and their cargoes, as well as on other post-TGN carriers or routes, will be pertinent to the NCLs. By affecting some or all of these transport routes, mutations in CLN3 or btn1 might cause reduced levels of many enzymes in the lysosome or vacuole, affecting processing and maturation of important molecules and the degradative capacity of these organelles. These might include lysosomal hydrolases implicated in other types of NCL (Cooper et al., 2006
; Siintola et al., 2006
; Siintola et al., 2007
). A thorough study of the lysosome proteome has not been performed in cells completely lacking CLN3 function. However, in JNCL cells, or in cells in which CLN3 function is substantially or partially reduced, alterations in trafficking or processing of specific lysosomal enzymes have been reported (Fossale et al., 2004
; Junaid and Pullarkat, 1999
; Metcalfe et al., 2008; Pohl et al., 2007
; Sleat et al., 1998
), and lysosomal homeostasis is affected (Holopainen et al., 2001
; Kitzmüller et al., 2008
; Ramirez-Montealegre and Pearce, 2005
). In one instance, exit of a reporter version of the cation-independent M6PR from the TGN was significantly reduced when CLN3 was depleted (Metcalfe et al., 2008). Trafficking defects arising from CLN3 dysfunction might underlie other clinically significant phenotypic effects. For example, aberrant processing of amyloid precursor protein (APP) in neurons, a hallmark for Alzheimer's disease, also reported in JNCL (Golabek et al., 2000
; Kitaguchi et al., 1990
; Villanova et al., 1999
; Wisniewski et al., 1992
; Wisniewski et al., 1990
), could be explained by defective trafficking of the sortilin SORL1 (Andersen et al., 2005
).
Our findings do not necessarily contradict previous work in mammalian systems that concluded that the functional location for CLN3 was the lysosome. Endogenous levels of CLN3, like Btn1p, are low; hence the need for overexpression of CLN3, which might have distorted its subcellular distribution. Nevertheless, a recent study (Storch et al., 2007
) concluded that, like Btn1p in S. pombe, trafficking of wild-type CLN3 to lysosomes was considerably slower than lysosome membrane-resident proteins, and that CLN3 remains in the Golgi compartment for a significant time. Indeed, a location of CLN3 in the Golgi has been noted previously (Haskell et al., 1999
; Kremmidiotis et al., 1999
). Importantly, yeast genetics have allowed us to study the effects of complete absence of btn1, which is particularly important in the light of our recent finding that cells from JNCL patients retain partial CLN3 function (Kitzmüller et al., 2008
).
In conclusion, our data show that Btn1p, and by inference, CLN3, act in the Golgi compartment to affect the exit of at least one sorting receptor, thereby causing defective TGN-to-vacuole (lysosome) protein sorting. This important finding should help to uncover the mechanism of action of these proteins, and the precise consequences when such proteins are mutated.
| Materials and Methods |
|---|
|
|
|---|
Fluorescence staining and microscopy
FM4-64 dye (Molecular Probes) was dissolved in DMSO at a concentration of 0.82 mM. 2 µl FM4-64 stock was added to 1 ml log phase cells grown as indicated (typically 2.5x106 cells/ml). For vacuole labelling, cells were exposed to FM4-64 for 30 minutes, washed, and chased for 40 minutes to allow all dye to reach the vacuole. For assessment of Golgi position and number, in three independent experiments, similarly sized interphase cells were monitored by confocal microscopy for the number and distribution of Gms1p-CFP-positive compartments in the focal plane that bisected the nucleus (n>200 Golgi for each independent experiment). Since this marker gave a diffuse background, only distinct punctae in that plane were counted, and the mean ± s.d. calculated [numbers were comparable to those in Vjestica et al. (Vjestica et al., 2008
)]. Distribution was recorded by reference to distance from the centre of the nucleus. Maximum projection images of 0.3 µm z-sections through cells expressing Gms1p-CFP were used to display all Golgi compartments. The significance of changes in total Golgi number in one plane was assessed by performing unpaired Student's t-tests (95% confidence interval), using a critical P-value of 0.05. Images were visualised by either fluorescence or confocal microscopy, as indicated. Fluorescence microscopy was performed using a Hamamatsu digital camera C4742-95 fitted to a Zeiss Axioskop microscope with plan-Apochromat x63 1.25 NA oil objective and images were recorded using OpenLab 3.4 software (Improvision). A FITC filter was used for GFP and YFP detection, and a Rhodamine filter for detection of FM4-64. Confocal images were acquired using a Leica TCS SPE confocal imaging system with plan-Apochromat x63 1.25 NA oil objective and recorded using Leica LAS AF software. Images were opened and assembled in ImageJ. All images were downloaded to either Microsoft Excel for analysis, or to Adobe Photoshop 7 and Illustrator for assembly into montages. Z-stacks for movies (14 images acquired at 0.3 µm intervals) were captured by confocal microscopy and converted to avi images in ImageJ software for viewing in Quicktime. Maximum Z-projection images were obtained using ImageJ software.
Colony dot blots and western analysis
Immunoblot analysis to detect secreted Cpy1p was performed as described (Iwaki et al., 2006
), with modifications. 1x107 cells were spotted onto nitrocellulose membrane laid on YES or MM agar plates and grown for indicated times, normally 6 hours at 25°C. After removing cells by washing, nitrocellulose membranes were subjected to immunodetection of Cpy1p using S. pombe specific anti-Cpy1p antibody (1:500), kindly provided by Dr Kaoru Takegawa, Kagawa University, Japan. Densitometry of colony blots was performed using a Bio-Rad GS-800 calibrated densitometer, and measurements were acquired using QuantityOne software (Version 4.6). Typically, the density units over three independent experiments were recorded, the means calculated and plotted as relative mean density values ± s.d. (relative to wild-type levels), enabling comparison within and between experiments using the same experimental conditions (e.g. growth media). The significance of changes in Cpy1p secretion was assessed by performing unpaired Student's t-tests (95% confidence interval), using a critical P-value of 0.05. Protein expression was verified by fluorescence microscopy when the effect of this expression on Cpy1p secretion was under investigation.
Golgi inhibition
Brefeldin A (BFA, Sigma) (dissolved in DMSO at 10 mg/ml) was used to disrupt the Golgi complex. Briefly, BFA was added to equivalent numbers of log-phase cells in 1 ml at a final concentration of 100 µg/ml. Cells were rotated at 25°C and visualised at 1 hour or 2 hour intervals. Control experiments were performed using the equivalent concentration of DMSO.
High-pressure freezing EM using EMPACT system
Samples in log-phase growth were collected by filtration and immediately loaded into 1.5 mm hats and frozen under high pressure using the Leica EMPACT system (Leica, Vienna, Austria) according to the manufacturer's instructions. To visualise Golgi, freeze substitution was carried out using a Leica AFS freeze substitution unit with the following protocol: 2% osmium tetroxide in acetone at –90°C 6 hours, –60°C 6 hours, –30°C 6 hours, followed by an acetone wash –30°C to 20°C. Samples were embedded in epoxy resin (EPON; TAAB Laboratories). Sections were cut with a Leica Ultracut UCT microtome onto formvar-coated slot grids, stained with lead citrate, and viewed with a transmission electron microscope (TECNAI12: Philips, Eindhoven, The Netherlands). Images were acquired using a Morada digital camera (Olympus-SIS) and assembled in Adobe Photoshop. Golgi complexes were defined morphologically as electron-dense single or multiple adjacent ribbon-like tubules or cisternae.
| Footnotes |
|---|
We thank Kaoru Takegawa for supplying strains, plasmids and the anti-Cpy1p antibody; Snezhana Oliferenko for supplying strains; Lucy Collinson for assistance with EM; Rebecca Haines, Claudia Kitzmüller, Mark Marsh, Martin Raff and Katherine Bowers for helpful discussion. This work was supported by the Medical Research Council, UK (core support to the LMCB), the European Commission (503051), the Wellcome Trust, UK (067991, and Value in People Award with UCL) and UCL. We thank the Children's Brain Diseases Foundation, USA, for additional financial support. Deposited in PMC for release after 6 months.
| References |
|---|
|
|
|---|
Andersen, O. M., Reiche, J., Schmidt, V., Gotthardt, M., Spoelgen, R., Behlke, J., von Arnim, C. A., Breiderhoff, T., Jansen, P., Wu, X. et al. (2005). Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc. Natl. Acad. Sci. USA 102, 13461-13466.
Ayscough, K., Hajibagheri, N. M. A., Watson, R. and Warren, G. (1993). Stacking of Golgi cisternae in Schizosaccharomyces pombe requires intact mictrotubules. J. Cell Sci. 106, 1227-1237.[Abstract]
Baldwin, S. A., Beal, P. R., Yao, S. Y., King, A. E., Cass, C. E. and Young, J. D. (2004). The equilibrative nucleoside transporter family, SLC29. Pflugers Arch. 447, 735-743.[CrossRef][Medline]
Bellemare, D. R., Shaner, L., Morano, K. A., Beaudoin, J., Langlois, R. and Labbe, S. (2002). Ctr6, a vacuolar membrane copper transporter in Schizosaccharomyces pombe. J. Biol. Chem. 277, 46676-46686.
Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N., Engelman, A., Xavier, R. J., Lieberman, J. and Elledge, S. J. (2008). Identification of host proteins required for HIV infection through a functional genomic screen. Science 319, 921-926.
Brazer, S. C., Williams, H. P., Chappell, T. G. and Cande, W. Z. (2000). A fission yeast kinesin affects Golgi membrane recycling. Yeast 16, 149-166.[CrossRef][Medline]
Burda, P., Padilla, S. M., Sarkar, S. and Emr, S. D. (2002). Retromer function in endosome-to-Golgi retrograde transport is regulated by the yeast Vps34 PtdIns 3-kinase. J. Cell Sci. 115, 3889-3900.
Cao, Y., Espinola, J. A., Fossale, E., Massey, A. C., Cuervo, A. M., Macdonald, M. E. and Cotman, S. L. (2006). Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis. J. Biol. Chem. 281, 20483-20493.
Cereghino, J. L., Marcusson, E. G. and Emr, S. D. (1995). The cytoplasmic tail domain of the vacuolar protein sorting receptor Vps10p and a subset of VPS gene products regulate receptor stability, function, and localization. Mol. Biol. Cell 6, 1089-1102.[Abstract]
Chappell, T. G. and Warren, G. (1989). A galactosyltransferase from the fission yeast Schizosaccharomyces pombe. J. Cell Biol. 109, 2693-2702.
Chattopadhyay, S., Muzaffar, N. E., Sherman, F. and Pearce, D. A. (2000). The yeast model for Batten disease: mutations in BTN1, BTN2, and HSP30 alter pH homeostasis. J. Bacteriol. 182, 6418-6423.
Codlin, S., Haines, R. L., Burden, J. J. E. and Mole, S. E. (2008a). btn1 affects cytokinesis and cell wall deposition by independent mechanisms, one of which is linked to vacuole pH dysregulation. J. Cell Sci. 121, 2860-2870.
Codlin, S., Haines, R. L. and Mole, S. E. (2008b). btn1 affects endocytosis, polarisation of sterol-rich membrane domains and polarised growth in Schizosaccharomyces pombe. Traffic 9, 936-950.[CrossRef][Medline]
The International Batten Disease Consortium (1995). Isolation of a novel gene underlying Batten disease, CLN3. Cell 82, 949-957.[CrossRef][Medline]
Cooper, A. A. and Stevens, T. H. (1996). Vps10p cycles between the late-Golgi and prevacuolar compartments in its function as the sorting receptor for multiple yeast vacuolar hydrolases. J. Cell Biol. 133, 529-541.
Cooper, J. D., Russell, C. and Mitchison, H. M. (2006). Progress towards understanding disease mechanisms in small vertebrate models of neuronal ceroid lipofuscinosis. Biochim. Biophys. Acta 1762, 873-889.[Medline]
Dahms, N. M., Lobel, P. and Kornfeld, S. (1989). Mannose 6-phosphate receptors and lysosomal enzyme targeting. J. Biol. Chem. 264, 12115-12118.
De Matteis, M. A. and Luini, A. (2008). Exiting the Golgi complex. Nat. Rev. Mol. Cell Biol. 9, 273-284.[CrossRef][Medline]
Deloche, O., Yeung, B. G., Payne, G. S. and Schekman, R. (2001). Vps10p transport from the trans-Golgi network to the endosome is mediated by clathrin-coated vesicles. Mol. Biol. Cell 12, 475-485.
Donaldson, J. G., Honda, A. and Weigert, R. (2005). Multiple activities for Arf1 at the Golgi complex. Biochim. Biophys. Acta 1744, 364-373.[Medline]
Ezaki, J., Takeda-Ezaki, M., Koike, M., Ohsawa, Y., Taka, H., Mineki, R., Murayama, K., Uchiyama, Y., Ueno, T. and Kominami, E. (2003). Characterization of Cln3p, the gene product responsible for juvenile neuronal ceroid lipofuscinosis, as a lysosomal integral membrane glycoprotein. J. Neurochem. 87, 1296-1308.[CrossRef][Medline]
Finn, R. D., Mistry, J., Schuster-Bockler, B., Griffiths-Jones, S., Hollich, V., Lassmann, T., Moxon, S., Marshall, M., Khanna, A., Durbin, R. et al. (2006). Pfam: clans, web tools and services. Nucl. Acids Res. 34, D247-D251.
Fossale, E., Wolf, P., Espinola, J. A., Lubicz-Nawrocka, T., Teed, A. M., Gao, H., Rigamonti, D., Cattaneo, E., MacDonald, M. E. and Cotman, S. L. (2004). Membrane trafficking and mitochondrial abnormalities precede subunit c deposition in a cerebellar cell model of juvenile neuronal ceroid lipofuscinosis. BMC Neurosci. 5, 57.[CrossRef][Medline]
Futter, C. E., Collinson, L. M., Backer, J. M. and Hopkins, C. R. (2001). Human VPS34 is required for internal vesicle formation within multivesicular endosomes. J. Cell Biol. 155, 1251-1264.
Gachet, Y., Codlin, S., Hyams, J. S. and Mole, S. E. (2005). btn1, the fission yeast homologue of the human Batten disease gene, CLN3, regulates vacuole homeostasis. J. Cell Sci. 118, 5525-5536.
Gaits, F. and Russell, P. (1999). Vacuole fusion regulated by protein phosphatase 2C in fission yeast. Mol. Biol. Cell 10, 2647-2654.
Golabek, A. A., Kida, E., Walus, M., Kaczmarski, W., Michalewski, M. and Wisniewski, K. E. (2000). CLN3 protein regulates lysosomal pH and alters intracellular processing of Alzheimer's amyloid-beta protein precursor and cathepsin D in human cells. Mol. Genet. Metab. 70, 203-213.[CrossRef][Medline]
Hall, B. S., Gabernet-Castello, C., Voak, A., Goulding, D., Natesan, S. K. and Field, M. C. (2006). TbVps34, the trypanosome orthologue of Vps34, is required for Golgi complex segregation. J. Biol. Chem. 281, 27600-27612.
Haskell, R. E., Derksen, T. A. and Davidson, B. L. (1999). Intracellular trafficking of the JNCL protein CLN3. Mol. Genet. Metab. 66, 253-260.[CrossRef][Medline]
Haskell, R. E., Carr, C. J., Pearce, D. A., Bennett, M. J. and Davidson, B. L. (2000). Batten disease: evaluation of CLN3 mutations on protein localization and function. Hum. Mol. Genet. 9, 735-744.
Hobert, J. A. and Dawson, G. (2007). A novel role of the Batten disease gene CLN3: association with BMP synthesis. Biochem. Biophys. Res. Commun. 358, 111-116.[CrossRef][Medline]
Holopainen, J. M., Saarikoski, J., Kinnunen, P. K. and Järvelä, I. (2001). Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs). Eur. J. Biochem. 268, 5851-5856.[Medline]
Iwaki, T., Osawa, F., Onishi, M., Koga, T., Fujita, Y., Hosomi, A., Tanaka, N., Fukui, Y. and Takegawa, K. (2003). Characterization of vps33+, a gene required for vacuolar biogenesis and protein sorting in Schizosaccharomyces pombe. Yeast 20, 845-855.[CrossRef][Medline]
Iwaki, T., Goa, T., Tanaka, N. and Takegawa, K. (2004). Characterization of Schizosaccharomyces pombe mutants defective in vacuolar acidification and protein sorting. Mol. Genet. Genomics 271, 197-207.[CrossRef][Medline]
Iwaki, T., Hosomi, A., Tokudomi, S., Kusunoki, Y., Fujita, Y., Giga-Hama, Y., Tanaka, N. and Takegawa, K. (2006). Vacuolar protein sorting receptor in Schizosaccharomyces pombe. Microbiology 152, 1523-1532.
Järvelä, I., Sainio, M., Rantamaki, T., Olkkonen, V. M., Carpén, O., Peltonen, L. and Jalanko, A. (1998). Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease. Hum. Mol. Genet. 7, 85-90.
Järvelä, I., Lehtovirta, M., Tikkanen, R., Kyttälä, A. and Jalanko, A. (1999). Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL). Hum. Mol. Genet. 8, 1091-1098.
Junaid, M. A. and Pullarkat, R. K. (1999). Increased brain lysosomal pepstatin-insensitive proteinase activity in patients with neurodegenerative diseases. Neurosci. Lett. 264, 157-160.[CrossRef][Medline]
Kihara, A., Noda, T., Ishihara, N. and Ohsumi, Y. (2001). Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae. J. Cell Biol. 152, 519-530.
Kim, Y., Ramirez-Montealegre, D. and Pearce, D. A. (2003). A role in vacuolar arginine transport for yeast Btn1p and for human CLN3, the protein defective in Batten disease. Proc. Natl. Acad. Sci. USA 100, 15458-15462.
Kitaguchi, T., Wisniewski, K. E., Maslinski, S., Maslinska, D., Wisniewski, T. M. and Kim, K. S. (1990). Beta-protein immunoreactivity in brains of patients with neuronal ceroid lipofuscinosis: ultrastructural and biochemical demonstration. Neurosci. Lett. 112, 155-160.[CrossRef][Medline]
Kitzmüller, C., Haines, R., Codlin, S., Cutler, D. F. and Mole, S. E. (2008). A function retained by the common mutant CLN3 protein is responsible for the late onset of juvenile neuronal ceroid lipofuscinosis (JNCL). Hum. Mol. Genet. 17, 303-312.
Kremmidiotis, G., Lensink, I. L., Bilton, R. L., Woollatt, E., Chataway, T. K., Sutherland, G. R. and Callen, D. F. (1999). The Batten disease gene product (CLN3p) is a Golgi integral membrane protein. Hum. Mol. Genet. 8, 523-531.
Kyttälä, A., Ihrke, G., Vesa, J., Schell, M. J. and Luzio, J. P. (2004). Two motifs target Batten disease protein CLN3 to lysosomes in transfected non-neuronal and neuronal cells. Mol. Biol. Cell 15, 1313-1323.
Lawe, D. C., Patki, V., Heller-Harrison, R., Lambright, D. and Corvera, S. (2000). The FYVE domain of early endosome antigen 1 is required for both phosphatidylinositol 3-phosphate and Rab5 binding. Critical role of this dual interaction for endosomal localization. J. Biol. Chem. 275, 3699-3705.
Lippincott-Schwartz, J., Yuan, L. C., Bonifacino, J. S. and Klausner, R. D. (1989). Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER. Cell 56, 801-813.[CrossRef][Medline]
Lobley, A., Swindells, M. B., Orengo, C. A. and Jones, D. T. (2007). Inferring function using patterns of native disorder in proteins. PLoS Comp. Biol. 3, e162.[CrossRef]
Luiro, K., Kopra, O., Lehtovirta, M. and Jalanko, A. (2001). CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease. Hum. Mol. Genet. 10, 2123-2131.
Luiro, K., Yliannala, K., Ahtiainen, L., Maunu, H., Järvelä, I., Kyttala, A. and Jalanko, A. (2004). Interconnections of CLN3, Hook1 and Rab proteins link Batten disease to defects in the endocytic pathway. Hum. Mol. Genet. 13, 3017-3027.
Metcalf, D. J., Calvi, A. A., Seaman, M. N. J., Mitchison, H. M. and Cutler, D. F. (2008). Loss of the Batten disease gene CLN3 prevents exit from the TGN of the mannose 6-phosphate receptor. Traffic 9, 1905-1914.[CrossRef][Medline]
McNiven, M. A. and Thompson, H. M. (2006). Vesicle formation at the plasma membrane and trans-Golgi network: the same but different. Science 313, 1591-1594.
Moreno, S., Klar, A. and Nurse, P. (1991). Molecular genetic analysis of fission yeast Schizosaccharomyces pombe. Methods Enzymol. 194, 795-823.[Medline]
Narayan, S. B., Rakheja, D., Tan, L., Pastor, J. V. and Bennett, M. J. (2006). CLN3P, the Batten's disease protein, is a novel palmitoyl-protein Delta-9 esaturase. Ann. Neurol. 60, 570-577.[CrossRef][Medline]
Nugent, T., Mole, S. E. and Jones, D. (2008). The transmembrane topology of Batten disease protein CLN3 determined by consensus computational prediction constrained by experimental data. FEBS Lett. 582, 1019-1024.[CrossRef][Medline]
Osorio, N. S., Carvalho, A., Almeida, A. J., Padilla-Lopez, S., Leao, C., Laranjinha, J., Ludovico, P., Pearce, D. A. and Rodrigues, F. (2007). Nitric oxide signaling is disrupted in the yeast model for Batten disease. Mol. Biol. Cell 18, 2755-2767.
Padilla-Lopez, S. and Pearce, D. A. (2006). Saccharomyces cerevisiae lacking Btn1p modulate vacuolar ATPase activity in order to regulate pH imbalance in the vacuole. J. Biol. Chem. 281, 10273-10280.
Patterson, G. H., Hirschberg, K., Polishchuk, R. S., Gerlich, D., Phair, R. D. and Lippincott-Schwartz, J. (2008). Transport through the Golgi apparatus by rapid partitioning within a two-phase membrane system. Cell 133, 1055-1067.[CrossRef][Medline]
Pearce, D. A. and Sherman, F. (1998). A yeast model for the study of Batten disease. Proc. Natl. Acad. Sci. USA 95, 6915-6918.
Pearce, D. A., Ferea, T., Nosel, S. A., Das, B. and Sherman, F. (1999). Action of BTN1, the yeast orthologue of the gene mutated in Batten disease. Nat. Genet. 22, 55-58.[CrossRef][Medline]
Persaud-Sawin, D. A., VanDongen, A. and Boustany, R. M. (2002). Motifs within the CLN3 protein: modulation of cell growth rates and apoptosis. Hum. Mol. Genet. 11, 2129-2142.
Persaud-Sawin, D. A., Mousallem, T., Wang, C., Zucker, A., Kominami, E. and Boustany, R. M. (2007). Neuronal ceroid lipofuscinosis: a common pathway? Pediatr. Res. 61, 146-152.[CrossRef][Medline]
Pidoux, A. L. and Armstrong, J. (1993). The BiP protein and the endoplasmic reticulum of Schizosaccharomyces pombe: fate of the nuclear envelope during cell division. J. Cell Sci. 105, 1115-1120.[Abstract]
Pohl, S., Mitchison, H. M., Kohlschutter, A., Diggelen, O. V., Braulke, T. and Storch, S. (2007). Increased expression of lysosomal acid phosphatase in CLN3-defective cells and mouse brain tissue. J. Neurochem. 103, 2177-2188.[CrossRef][Medline]
Ramirez-Montealegre, D. and Pearce, D. A. (2005). Defective lysosomal arginine transport in juvenile Batten disease. Hum. Mol. Genet. 14, 3759-3773.
Ridley, S. H., Ktistakis, N., Davidson, K., Anderson, K. E., Manifava, M., Ellson, C. D., Lipp, P., Bootman, M., Coadwell, J., Nazarian, A. et al. (2001). FENS-1 and DFCP1 are FYVE domain-containing proteins with distinct functions in the endosomal and Golgi compartments. J. Cell Sci. 114, 3991-4000.[Medline]
Robinson, J. S., Klionsky, D. J., Banta, L. M. and Emr, S. D. (1988). Protein sorting in Saccharomyces cerevisiae: isolation of mutants defective in the delivery and processing of multiple vacuolar hydrolases. Mol. Cell. Biol. 8, 4936-4948.
Rothman, J. H. and Stevens, T. H. (1986). Protein sorting in yeast: mutants defective in vacuole biogenesis mislocalize vacuolar proteins into the late secretory pathway. Cell 47, 1041-1051.[CrossRef][Medline]
Schaub, B. E., Berger, B., Berger, E. G. and Rohrer, J. (2006). Transition of galactosyltransferase 1 from trans-Golgi cisterna to the trans-Golgi network is signal mediated. Mol. Biol. Cell 17, 5153-5162.
Siintola, E., Lehesjoki, A. E. and Mole, S. E. (2006). Molecular genetics of the NCLs-status and perspectives. Biochim. Biophys. Acta 1762, 857-864.[Medline]
Siintola, E., Topcu, M., Aula, N., Lohi, H., Minassian, B. A., Paterson, A. M., Liu, X.-Q., Wilson, C., Lahtinen, U., Anottonen, A.-K. et al. (2007). The novel neuronal ceroid lipofusinosis gene MFSD8 encodes a putative lysosomal transporter. Am. J. Hum. Genet. 81, 136-146.[CrossRef][Medline]
Sleat, D. E., Sohar, I., Pullarkat, P. S., Lobel, P. and Pullarkat, R. K. (1998). Specific alterations in levels of mannose 6-phosphorylated glycoproteins in different neuronal ceroid lipofuscinoses. Biochem. J. 334, 547-551.[Medline]
Stack, J. H., DeWald, D. B., Takegawa, K. and Emr, S. D. (1995). Vesicle-mediated protein transport: regulatory interactions between the Vps15 protein kinase and the Vps34 PtdIns 3-kinase essential for protein sorting to the vacuole in yeast. J. Cell Biol. 129, 321-334.
Storch, S., Pohl, S., Quitsch, A., Falley, K. and Braulke, T. (2007). C-terminal prenylation of the CLN3 membrane glycoprotein is required for efficient endosomal sorting to lysosomes. Traffic 8, 431-444.[CrossRef][Medline]
Tabuchi, M., Iwaihara, O., Ohtani, Y., Ohuchi, N., Sakurai, J., Morita, T., Iwahara, S. and Takegawa, K. (1997). Vacuolar protein sorting in fission yeast: cloning, biosynthesis, transport, and processing of carboxypeptidase Y from Schizosaccharomyces pombe. J. Bacteriol. 179, 4179-4189.
Takegawa, K., DeWald, D. B. and Emr, S. D. (1995). Schizosaccharomyces pombe Vps34p, a phosphatidylinositol-specific PI 3-kinase essential for normal cell growth and vacuole morphology. J. Cell Sci. 108, 3745-3756.[Abstract]
Tanaka, N. and Takegawa, K. (2001). Functional characterization of Gms1p/UDP-galactose transporter in Schizosaccharomyces pombe. Yeast 18, 745-757.[CrossRef][Medline]
Valls, L. A., Winther, J. R. and Stevens, T. H. (1990). Yeast carboxypeptidase Y vacuolar targeting signal is defined by four propeptide amino acids. J. Cell Biol. 111, 361-368.
Villanova, M., Ceuterick, C., Dotti, M. T., Santorelli, F. M., Casali, C., Malandrini, A., De Stefano, N., Lubke, U., Martin, J. J., Guazzi, G. C. et al. (1999). Detection of beta-A4 amyloid and its precursor protein in the muscle of a patient with juvenile neuronal ceroid lipofuscinosis (Spielmeyer-Vogt-Sjogren). Acta Neuropathol. 98, 78-84.[CrossRef][Medline]
Vjestica, A., Tang, X. Z. and Oliferenko, S. (2008). The actomyosin ring recruits early secretory compartments to the division site in fission yeast. Mol. Biol. Cell 19, 1125-1138.
Whyte, J. R. and Munro, S. (2001). A yeast homolog of the mammalian mannose 6-phosphate receptors contributes to the sorting of vacuolar hydrolases. Curr. Biol. 11, 1074-1078.[CrossRef][Medline]
Wisniewski, K. E., Maslinska, D., Kitaguchi, T., Kim, K. S., Goebel, H. H. and Haltia, M. (1990). Topographic heterogeneity of amyloid B-protein epitopes in brains with various forms of neuronal ceroid lipofuscinoses suggesting defective processing of amyloid precursor protein. Acta Neuropathol. 80, 26-34.[CrossRef][Medline]
Wisniewski, K. E., Gordon-Majszak, W., Maslinski, S. and Heaney-Kieras, J. (1992). Altered protein patterns in brains of children with neuronal ceroid lipofuscinosis. Am. J. Med. Genet. 42, 568-574.[CrossRef][Medline]
Wurmser, A. E. and Emr, S. D. (2002). Novel PtdIns(3)P-binding protein Etf1 functions as an effector of the Vps34 PtdIns 3-kinase in autophagy. J. Cell Biol. 158, 761-772.
Yan, Y. and Backer, J. M. (2007). Regulation of class III (Vps34) PI3Ks. Biochem. Soc. Trans. 35, 239-241.[CrossRef][Medline]
Zeng, X., Overmeyer, J. H. and Maltese, W. A. (2006). Functional specificity of the mammalian Beclin-Vps34 PI 3-kinase complex in macroautophagy versus endocytosis and lysosomal enzyme trafficking. J. Cell Sci. 119, 259-270.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||